Official UK procurement notice
Histopathology Outsourcing for Portsmouth Hospitals University Trust Cellular Pathology department
Authority: Portsmouth Hospitals University NHS Trust (Central government)·Consortium: 2 public authorities
What is being bought
Published requirement descriptionOutsourcing of Histopathology cases, including provision of both laboratory technical and Consultant diagnostic reporting services, attendance at MDT.
CPV: Pathology services
The lotProcurement structure
single lot · no lot value publishedLot #1Outsourcing of Histopathology cases, including provision of both laboratory technical…Awarded
Outsourcing of Histopathology cases, including provision of both laboratory technical and Consultant diagnostic reporting services, attendance at MDT, courier services
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 16 Aug 2024, 15:29 BST
- Last source update
- 12 Jan 2026, 10:40 GMT
- Authority reference
C241292 - Q14873- FTS notice number
2026/S 000-002157- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-048bb9Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
'This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by [Add date]. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'.
Publisher note: 'This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by [Add date]. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.' The email address where written representations should be sent is [email protected] The award decision-makers are the Cellular Pathology Laboratory Manager and the Clinical Support Care Group Manager There are no declared conflicts or potential conflicts of interest of individuals making the decision related to this award. In reviewing the Key Criteria, the following were considered to be the most important:- Value and service sustainability. In addition to this, continuing with Poundbury gives the Trust continuity of service having built up an existing relationship between PHU Pathologists, clinicians and surgical teams. Poundbury Pathologists attend PHU MDT's when required and are therefore experienced with the Trust's surgical and clinical processes. Poundbury Pathologists participate in the national dermal EQA scheme which is an ISO15189 accreditation standard requirement The provider was originally chosen by NHSE to provide post pandemic recovery Histopathology outsourcing support for breast screening and have further supported PHU with breast, skin, gynae, urology and GI reporting. The provider meets the basic selection criteria, in particular 'technical and professional ability' in that they offer specific technical expertise in Histopathology breast reporting and have established a relationship with PHU clinical teams so can discuss cases confidently at MDT, due to knowledge of PHU surgical and clinical processes. The PHU Cellular Pathology department now also have a deficit of reporting capacity for other tumour groups such as skin, gynae, upper and lower GI and Urology and have used this provider to support with further outsourcing, maintaining existing clinical relationships. The provider can offer Consultants registered with the relevant EQA schemes which is an important factor for patient safety and accreditation. The provider is considered to give good value, with a bespoke PHU pricing structure negotiated based upon workload points. The contract does not state minimum activity levels therefore PHU are not committed to sending a certain amount of work and can use the service as and when required.
Notice history
1 event · 2 releases on Find a Tender- Buyer details updated12 Jan 2026, 10:40 GMT
Published amendments (1 · 0 deadline changes)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | TextV.2.1 | Award of contract | 'This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C.' Date of contract award… |
1 amendment published without a description.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Poundbury Cancer InstituteSME | £950,000 † | — | Awarded |
Contracts
Contract 026184-2024-1 · Poundbury Cancer InstituteSME
- Signed
- 15 Aug 2024
- Value
- £950,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- South of England Procurement CentreContracting authorityRegional or local authorityHealth
Dispute resolution & review bodies
- This is not mandatory under the PSRReview body
Bidders & participating suppliers
1 commercial party on the notice- Poundbury Cancer InstituteAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.